Painkillers may be used after a stem cell injection, but the type of medication matters. Paracetamol, also known as acetaminophen, is often considered when simple pain relief is needed. Nonsteroidal anti-inflammatory drugs, or NSAIDs, are treated more cautiously in many regenerative medicine protocols.
The reason is not that NSAIDs have been proven to make stem cell therapy fail. Rather, laboratory and animal research suggests that some NSAIDs can influence processes involving mesenchymal stem cells and inflammation. Human evidence is still limited, and there is no universally accepted rule for how long NSAIDs should be avoided after an MSC injection.
For this reason, patients should follow the instructions provided by their treating physician rather than stopping, starting, or changing medication on their own.
Why Can a Stem Cell Injection Be Painful Afterwards?
Temporary soreness can occur after an intra-articular stem cell injection. The needle itself can irritate tissue, and introducing fluid into a joint may temporarily create pressure, tightness, or swelling. Some patients notice very little discomfort, while others experience increased soreness during the early period after treatment.
This does not automatically mean that something has gone wrong. It also does not mean that a stronger pain response indicates better regeneration.
Pain that is severe, continues to worsen, or occurs together with significant swelling, warmth, redness, fever, or difficulty moving the joint should be assessed by the treating medical team.
Why Are NSAIDs Often Avoided After Stem Cell Treatment?
NSAIDs reduce pain partly by interfering with cyclooxygenase enzymes and prostaglandin production. Common examples include ibuprofen, naproxen, diclofenac, and some COX-2 selective medications.
This anti-inflammatory action is useful for many conditions. In regenerative medicine, however, there is ongoing discussion about whether suppressing inflammatory pathways around the time of treatment could influence some of the biological processes involved in tissue repair.
Laboratory research has shown that certain NSAIDs can influence MSC behavior, including processes related to cell differentiation. However, the effects vary depending on the medication, concentration, cell source, and biological process being studied.
More importantly, there is currently not enough high-quality human evidence to show that taking NSAIDs after UC-MSC treatment reduces clinical effectiveness. This is why avoiding NSAIDs is best described as a precautionary approach used in many regenerative medicine protocols, rather than a proven requirement for every patient.
Do NSAIDs Kill Stem Cells?
Saying that NSAIDs simply “kill stem cells” is not scientifically accurate. Different NSAIDs can affect different cellular pathways, and their effects may depend on concentration, duration of exposure, cell source, and the type of tissue response being studied.
Some laboratory studies have reported changes in MSC proliferation or differentiation. Others have found relatively limited effects on certain cellular functions.
More importantly, laboratory experiments expose cells to medications under controlled conditions that do not perfectly reproduce what happens inside a human joint.
The current evidence therefore supports caution, but it does not justify telling patients that taking one NSAID tablet will destroy an MSC treatment.
What Does the Clinical Research Say About Avoiding NSAIDs?
There is no standardized post-treatment medication protocol across regenerative medicine. A 2025 scoping review examined post-procedure instructions used in 200 clinical studies of intra-articular orthobiologic treatments. Among studies that reported post-procedure protocols, NSAID restriction was very common. However, the duration of those restrictions varied substantially. The authors concluded that post-treatment protocols remain inconsistent and that better research is needed.
It is important to note that this review primarily evaluated treatments such as platelet-rich plasma, bone marrow aspirate concentrate, and microfragmented adipose tissue. It excluded culture-expanded and perinatal cell products, so its findings cannot simply be applied directly to UC-MSC therapy.
There is currently insufficient high-quality human evidence to define an exact NSAID avoidance period specifically for UC-MSC joint injections. This explains why recommendations can differ between clinics and treatment protocols.
Is Paracetamol Different From an NSAID?
Yes. Paracetamol, also called acetaminophen, is primarily used to reduce pain and fever and has much weaker peripheral anti-inflammatory activity than traditional NSAIDs.
For this reason, physicians may consider paracetamol when pain relief is needed but they wish to avoid stronger anti-inflammatory medication.
However, this should not be interpreted as proof that paracetamol has absolutely no biological interaction with MSCs. Laboratory studies have examined its effects on MSC gene expression, and the complete relationship between pain medications and cell-based therapies remains incompletely understood.
The practical difference is that paracetamol does not produce the same peripheral anti-inflammatory effect as medications such as ibuprofen, naproxen, or diclofenac.
This is one reason it may be considered for short-term pain control after a regenerative procedure when medically appropriate.
Is Paracetamol Safe for Everyone?
No medication is appropriate for every patient. Paracetamol is widely used, but excessive amounts can cause serious liver injury. Patients also need to be aware that acetaminophen may be contained in more than one medication, including some combination cold, flu, and prescription pain medicines.
People with liver disease, significant alcohol use, or other medical considerations should discuss its use with their physician. Patients should follow the recommended dose and should not take additional paracetamol simply because their post-injection pain has not improved.
The fact that a medication is available without a prescription does not mean it should be taken without considering the patient’s medical history.
What About Aspirin?
Aspirin requires special consideration because some patients take it for cardiovascular or cerebrovascular reasons rather than simply for pain.
A patient taking prescribed aspirin to reduce the risk of a heart attack, stroke, or another vascular event should not stop it independently because of a stem cell procedure.
The risks of interrupting medically necessary antiplatelet treatment may be more important than a theoretical concern about its interaction with a regenerative treatment.
The treating physician should review why the medication is being taken and, when necessary, coordinate with the doctor who prescribed it.
This principle also applies to other medications that may have been prescribed for an important underlying condition.
Why Do Different Clinics Give Different Instructions?
Part of the reason is that the evidence is still incomplete. Regenerative medicine includes very different products. PRP, bone marrow aspirate concentrate, adipose-derived products, and culture-expanded MSCs are not biologically identical treatments. Evidence about medication use with one product cannot always be transferred directly to another.
Protocols also differ according to the treated tissue, the patient’s medical history, the medication being considered, and the physician’s interpretation of available evidence.
Research examining post-procedure orthobiologic protocols has found substantial variation in medication restrictions, rehabilitation, weightbearing, and return to activity.
Variation does not necessarily mean one physician is correct and another is wrong. In many areas, it reflects the fact that clinical practice has developed faster than the evidence needed to establish one universal protocol.
Should You Stop NSAIDs Before or After Treatment on Your Own?
No. Patients should not stop prescribed medication simply because they have read that NSAIDs may interfere with regenerative medicine.
Some people take NSAIDs or aspirin for conditions unrelated to their joint pain. Others may have kidney disease, cardiovascular disease, gastrointestinal conditions, or other health factors that influence which pain medication is appropriate.
Medication decisions should therefore consider the entire patient, not only the stem cell procedure.
Before treatment, patients should provide their physician with a complete list of prescription medications, over-the-counter medicines, supplements, and painkillers they use regularly.
If medication changes are recommended, the physician can explain which medication should be adjusted, why, and for how long.
What Should You Do If Pain Becomes Severe After the Injection?
Pain medication should not be used to hide symptoms that may require medical assessment.
Some soreness after an intra-articular injection can occur. Severe or progressively worsening pain is different, particularly when it occurs with substantial swelling, redness, warmth, fever, chills, or difficulty bearing weight.
In these situations, taking stronger pain medication and waiting for the symptoms to disappear may delay appropriate assessment.
Patients should contact their treating medical team so the cause of the pain can be evaluated.
How Should Pain Be Managed After a Stem Cell Injection?
Pain management after a stem cell injection should balance comfort with the patient’s medical history and the treatment protocol.
Paracetamol may be considered for some patients when simple pain relief is needed. NSAIDs are often approached more cautiously because laboratory and animal studies raise questions about their interaction with MSC biology. However, human evidence remains insufficient to prove that NSAIDs reduce the effectiveness of UC-MSC treatment or to establish one universal avoidance period.
The most appropriate approach is therefore individualized. Patients should know which medications their physician permits before leaving the clinic. They should also understand when post-injection pain is expected and when worsening symptoms require medical review.
Frequently Asked Questions
- Can I take paracetamol after a stem cell injection?
Paracetamol may be considered for short-term pain relief after treatment when medically appropriate. Patients should follow their physician’s instructions, particularly if they have liver disease, regularly consume alcohol, or take other medications containing paracetamol.
- Can I take ibuprofen after a stem cell injection?
Many regenerative medicine protocols recommend avoiding NSAIDs such as ibuprofen around the time of treatment. However, there is no universally established avoidance period specifically for UC-MSC therapy. Ask the treating physician before taking it.
- Should I stop aspirin before stem cell treatment?
Not without medical advice. Aspirin may be prescribed for important cardiovascular or cerebrovascular reasons. Patients taking prescribed aspirin should discuss it with the treating physician and should not discontinue it independently.
Related Reading
- Why Does Pain Sometimes Get Worse After a Stem Cell Injection?
- Are PRP and Stem Cells the Same Thing? Understanding One of the Biggest Misconceptions in Regenerative Medicine
- Why Rehabilitation Matters After Stem Cell Therapy
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Kruse RC, Rossmiller KD, Fleagle TR. Postprocedure protocols after intraarticular orthobiologic injections: A scoping review. PM&R. 2025. https://pubmed.ncbi.nlm.nih.gov/39382011/
- Sok D, Raval S, McKinney J, et al. NSAIDs Reduce Therapeutic Efficacy of Mesenchymal Stromal Cell Therapy in a Rodent Model of Posttraumatic Osteoarthritis. American Journal of Sports Medicine. 2022. https://pubmed.ncbi.nlm.nih.gov/35420503/
- Pountos I, Giannoudis PV, Jones E, et al. NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man. Journal of Cellular and Molecular Medicine. 2011. https://pubmed.ncbi.nlm.nih.gov/20070439/
- Chang JK, Li CJ, Wu SC, et al. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochemical Pharmacology. 2007. https://pubmed.ncbi.nlm.nih.gov/17714695/
- Chang JK, Li CJ, Liao HJ, Wang CK, Wang GJ, Ho ML. Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells. Journal of Orthopaedic Research. 2013. https://pubmed.ncbi.nlm.nih.gov/23231452/